Clinical details
| Variable |
Controls (n=20) | Normal LV cavity (n=25) | Dilated LV cavity and restrictive filling (n=30) |
| Age (years) | 58 (11) | 63 (10) | 63 (9) |
| Male:female | 5:12 | 16:9 | 27:3 |
| EDD (cm) | 5.0 (0.5) | 4.9 (0.5) | 6.9 (0.8)1-150 |
| ESD (cm) | 3.4 (0.5) | 3.3 (0.5) | 5.9 (0.9)1-150 |
| SF (%) | 34 (8) | 32 (8) | 17 (5)1-150 |
| IVRT (ms) | 59 (11) | 62 (16) | (14)1-150 |
| E decel (ms) | 148 (15) | 144 (20) | 79 (19)1-150 |
| Clinical history | |||
| Myocardial infarction | 8 | 16 | |
| Diabetes | 4 | 3 | |
| Hypertension | 5 | 7 | |
| Medication | |||
| Diuretics | 0 | 24 | |
| Nitrates | 10 | 13 | |
| β Blocker | 9 | 10 | |
| ACE inhibitor | 12 | 26 | |
Values are mean (SD).
↵1-150 p < 0.001 versus control resting value.
ACE, angiotensin converting enzyme; E decel, E wave deceleration time; EDD, end diastolic dimension; ESD, end systolic dimension; IVRT, isovolumic relaxation time; LV, left ventricular; SF, shortening fraction